BIOMAT Database Logo BIOMAT Database Logo

Plasma growth hormone response to thyrotropin-releasing hormone in patients with active acromegaly. 1973

G Faglia, and P Beck-Peccoz, and C Ferrari, and P Travaglini, and B Ambrosi, and A Spada

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D005260 Female Females
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000172 Acromegaly A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80) Inappropriate Growth Hormone Secretion Syndrome (Acromegaly),Somatotropin Hypersecretion Syndrome (Acromegaly),Inappropriate GH Secretion Syndrome (Acromegaly),Hypersecretion Syndrome, Somatotropin (Acromegaly),Hypersecretion Syndromes, Somatotropin (Acromegaly),Somatotropin Hypersecretion Syndromes (Acromegaly),Syndrome, Somatotropin Hypersecretion (Acromegaly),Syndromes, Somatotropin Hypersecretion (Acromegaly)
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001120 Arginine An essential amino acid that is physiologically active in the L-form. Arginine Hydrochloride,Arginine, L-Isomer,DL-Arginine Acetate, Monohydrate,L-Arginine,Arginine, L Isomer,DL Arginine Acetate, Monohydrate,Hydrochloride, Arginine,L Arginine,L-Isomer Arginine,Monohydrate DL-Arginine Acetate

Related Publications

G Faglia, and P Beck-Peccoz, and C Ferrari, and P Travaglini, and B Ambrosi, and A Spada
Effect of glucocorticoids on the paradoxical growth hormone response to thyrotropin-releasing hormone in patients with acromegaly.
March 1995, Metabolism: clinical and experimental,
G Faglia, and P Beck-Peccoz, and C Ferrari, and P Travaglini, and B Ambrosi, and A Spada
Growth hormone-releasing hormone infusion in patients with active acromegaly.
July 1986, The Journal of clinical endocrinology and metabolism,
G Faglia, and P Beck-Peccoz, and C Ferrari, and P Travaglini, and B Ambrosi, and A Spada
Thyrotropin-releasing hormone increases serum levels of growth hormone-releasing hormone and growth hormone in patients with acromegaly.
September 1992, Journal of internal medicine,
G Faglia, and P Beck-Peccoz, and C Ferrari, and P Travaglini, and B Ambrosi, and A Spada
Serum growth hormone and prolactin response to thyrotropin-releasing hormone in patients with acromegaly before and after surgery.
June 1974, The Journal of clinical endocrinology and metabolism,
G Faglia, and P Beck-Peccoz, and C Ferrari, and P Travaglini, and B Ambrosi, and A Spada
Abnormal growth hormone responses to L-dopa and thyrotropin-releasing hormone in patients with acromegaly.
March 1977, The Tohoku journal of experimental medicine,
G Faglia, and P Beck-Peccoz, and C Ferrari, and P Travaglini, and B Ambrosi, and A Spada
Growth hormone response to thyrotropin-releasing hormone in cancer patients.
August 1980, Endocrinologia japonica,
G Faglia, and P Beck-Peccoz, and C Ferrari, and P Travaglini, and B Ambrosi, and A Spada
Paradoxical growth hormone response to thyrotropin-releasing hormone in acromegaly. Clinical correlations and prognostic value.
April 1990, Acta endocrinologica,
G Faglia, and P Beck-Peccoz, and C Ferrari, and P Travaglini, and B Ambrosi, and A Spada
Abnormal growth hormone responses to CB-154 and thyrotropin-releasing hormone (TRH) in patients with acromegaly.
January 1979, The Tohoku journal of experimental medicine,
G Faglia, and P Beck-Peccoz, and C Ferrari, and P Travaglini, and B Ambrosi, and A Spada
Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
July 1986, The Journal of clinical endocrinology and metabolism,
G Faglia, and P Beck-Peccoz, and C Ferrari, and P Travaglini, and B Ambrosi, and A Spada
Growth hormone response to thyrotropin-releasing hormone in diabetes.
May 1981, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!